Ferran Grau-Leal

Changes in serum CXCL13 levels are associated with outcomes of Colorectal Cancer Patients Undergoing First-Line Oxaliplatin-Based Treatment

E. Musulen, N. Mulet-Margalef, E. Martínez-Balibrea, 2024, medRxiv.